article thumbnail

Private Equity Investment in Health Care Providers and Technology – 2025 Midyear Outlook

JD Supra: Mergers

As of mid-2025, private equity (PE) investors remain intensely interested in health care services and technology companies despite higher borrowing costs, heightened regulatory scrutiny, and an increasingly complex state review landscape. By: ArentFox Schiff

article thumbnail

U.S. Private Equity Market Recap - April 2025

JD Supra: Mergers

private equity market. Read our latest insights into the U.S. We cover monthly deal activity and size, fundraising, exits, leveraged loans, and a look ahead. The drop in March deal count pushed Q1 deal count to the lowest quarterly level since the onset of the pandemic in Q2 2020.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The UK Takeover Panel’s Guidance on “Stub Equity” In Take-Private Transactions

JD Supra: Mergers

On 3 July 2025, the UK Takeover Panel (Panel) published a new Practice Statement 36 (PS 36), which provides formal guidance on how the Panel will interpret and apply the Takeover Code to an “unlisted share alternative” (known as stub equity) in the context of a take-private transaction of a UK public company.

Equities 171
article thumbnail

Momentum Shift: Canada’s M&A Landscape in 2025

JD Supra: Mergers

A variety of factors are expected to significantly increase Canadian M&A activity in 2025. We expect to enter 2025 with some positive momentum in Canadian dealmaking.

M&A 188
article thumbnail

U.S. Private Equity Market Recap - June 2025

JD Supra: Mergers

private equity market. PE deal market has been choppy in 2025 YTD as investors seek clarity on how various macroeconomic and geopolitical policies will play out. Growth: Growth equity has emerged as a bright spot within the PE deal market in 2025, with deal count and value both up over 50% YTD. Deal activity: The U.S.

article thumbnail

The PE Briefing: Q2 2025

JD Supra: Mergers

The clouds of uncertainty that rapidly formed in early 2025 continue to drift over the private equity landscape in Canada and globally. Tariffs and geopolitics are subduing deal making and investment opportunities, particularly in duty-exposed industries. Deeper and sharper due diligence means deals are taking longer to be done.

article thumbnail

DOJ Declines to Prosecute Private Equity Firm after Post-Acquisition Voluntary Self-Disclosure of Sanctions and Export Control Violations

JD Supra: Mergers

In its first application of the policy on voluntary self-disclosures (“VSDs”) in connection with mergers and acquisitions (“M&A”), on June 16, 2025, the US Department of Justice’s (“DOJ”) National Security Division (“NSD”) announced that it had declined to prosecute a US private equity firm after it voluntarily disclosed criminal violations of (..)